tiprankstipranks
Trending News
More News >
Aligos Therapeutics (ALGS)
NASDAQ:ALGS
US Market

Aligos Therapeutics (ALGS) Technical Analysis

Compare
213 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Aligos Therapeutics’s (ALGS) Moving Averages Convergence Divergence (MACD) indicator is 0.33, suggesting Aligos Therapeutics is a Sell.
Aligos Therapeutics’s (ALGS) 20-Day exponential moving average is 6.28, while Aligos Therapeutics’s (ALGS) share price is $7.3, making it a Buy.
Aligos Therapeutics’s (ALGS) 50-Day exponential moving average is 7.36, while Aligos Therapeutics’s (ALGS) share price is $7.3, making it a Buy.

Aligos Therapeutics (ALGS) Pivot Points

Jun 12, 2025, 05:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.98
6.44
6.87
7.33
7.76
8.22
8.65
Fibonacci
6.44
6.78
6.99
7.33
7.67
7.88
8.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aligos Therapeutics (ALGS) Moving Averages

Jun 12, 2025, 05:09 PM
Period
Simple
Exponential
MA5
7.13Buy
7.20Buy
MA10
6.41Buy
6.71Buy
MA20
6.07Buy
6.28Buy
MA50
5.58Buy
7.36Buy
MA100
12.24Sell
10.72Sell
MA200
15.73Sell
12.81Sell
Aligos Therapeutics’s (ALGS) 10-Day exponential moving average is 6.71, while Aligos Therapeutics’s (ALGS) share price is $7.3, making it a Buy.
Aligos Therapeutics’s (ALGS) 100-Day exponential moving average is 10.72, while Aligos Therapeutics’s (ALGS) share price is $7.3, making it a Sell.
Aligos Therapeutics’s (ALGS) stock price is $7.3 and Aligos Therapeutics’s (ALGS) 50-day simple moving average is 5.58, creating a Buy signal.
Aligos Therapeutics’s (ALGS) stock price is $7.3 and Aligos Therapeutics’s (ALGS) 100-day simple moving average is 12.24, creating a Sell signal.
Aligos Therapeutics’s (ALGS) stock price is $7.3 and Aligos Therapeutics’s (ALGS) 200-day simple moving average is 15.73, creating a Sell signal.

Aligos Therapeutics (ALGS) Technical Indicators

Jun 12, 2025, 05:09 PM
Name
Value
Implied Action
RSI (14)
67.84
Neutral
STOCH (9,6)
83.54
Sell
STOCHRSI (14)
83.54
Sell
MACD (12,26)
0.33
Sell
ADX (14)
20.43
Neutral
Williams %R
-8.85
Sell
CCI (14)
217.26
Sell
ATR (14)
0.75
-
Ultimate Oscillator
57.41
Neutral
ROC
40.14
Buy
Aligos Therapeutics’s (ALGS) Relative Strength Index (RSI) is 67.84, creating a Neutral signal.
Aligos Therapeutics’s (ALGS) Trend Strength Indicator (ADX) is 20.43, creating a Neutral signal.
Aligos Therapeutics’s (ALGS) Commodity Channel Index (CCI) is 217.26, creating a Sell signal.
Aligos Therapeutics’s (ALGS) Price Rate of Change (ROC) is 40.14, creating a Buy signal.

FAQ

Is ALGS a Buy, Hold, or Sell?
Based on ALGS’s technical indicators, ALGS is a Hold.
    What is ALGS’s RSI (14)?
    ALGS’s RSI (14) is 67.84, which suggests ALGS is a Neutral.
      What is ALGS’s MACD?
      ALGS’s MACD is 0.33, which suggests ALGS is a Sell.
        What is ALGS’s 5-day moving average?
        ALGS’s 5-day moving average is 7.13, which suggests ALGS is a Buy.
          What is ALGS’s 20-day moving average?
          ALGS 20-day moving average is 6.07, which suggests ALGS is a Buy.
            What is ALGS’s 50-day moving average?
            ALGS’s 50-day moving average is 5.58, which suggests ALGS is a Buy.
              What is ALGS’s 200-day moving average?
              ALGS’s 200-day moving average is 15.73, which suggests ALGS is a Sell.
                What is ALGS’s Williams % R (14)?
                ALGS’s Williams % R (14) is -8.85, which suggests ALGS is a Sell.
                  What is ALGS’s CCI (14)?
                  ALGS’s CCI (14) is 217.26, which suggests ALGS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis